The Simple BioTech Podcast

#14 - Tyler Golato - Decentralizing Drug Development For The Greater Public Good

Today is a very special episode where I will be discussing Biotech and Blockchain. Now you might be asking yourself - how do blockchain and biotech have anything to do with each other? That's exactly what i thought as well when I first heard of VitaDao. But after my conversation today I'm convinced that this is a collision of industries that was absolutely necessary. Vitadao is taking the world of crypto, and the world of BioTech and smashing them together in an explosion of innovation.  VitaDao is a completely decentralized autonomous organization... also know as a DAO... now there's a high likelihood that that sounds like a foreign language, and that a lot of you have never heard of a decentralized autonomous organization.. fear not, we go deep into exactly what that means in this episode. VitaDao is allowing any investor to invest in the absolute cutting edge BioTech technologies... the type of technologies that have so much potential, but carry so much risk, that the typical institutional investor or VC will pass on. This conversation blew me away... just wait until you hear what they're doing with BioTech IP and NFTs. I don't want to spoil too much but this is an episode you won't want to miss. Podcast notes and transcript available here: https://simplebiotechpodcast.com/tyler-golato-vitadao [https://simplebiotechpodcast.com/tyler-golato-vitadao] -James Ruhle, SimpleBioTechPodcast.com [https://simplebiotechpodcast.com/] Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech [http://instagram.com/simplebiotech] If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle [https://angel.co/jamesruhle]

#13 - Nora Khaldi - How Nuritas is using AI to Unlock the Miraculous Benefits in the Food We Eat Every Day

Locked in every bite of food we take is a universe of hidden potential. Potential to cure disease, help our sleep, and improve our mood just to name a few. The food we eat has a galaxy of molecules we call peptides, these peptides have limitless possibilities that get destroyed by the black hole we call our digestive system. These peptides have some truly miraculous healing qualities, but because of the extreme weakness in their bioavailability, to date humans have not been able to experience the benefits.  Enter Nuritas [https://www.nuritas.com/] - a company focusing on finding these miraculous peptides using AI technology, and extracting them from the food to become more bioavailable, essentially unlocking the full potential of the food that we eat. Dr. Nora khaldi is the brilliant woman behind Nuritas and today i had the pleasure of diving deep into the weeds with her while she explained just how this technology works, and what it means for human civilization going forward. So without further ado, Dr. Nora Khaldi. Podcast notes and transcript available here: https://simplebiotechpodcast.com/nora-khaldi-nuritas [https://simplebiotechpodcast.com/nora-khaldi-nuritas] -James Ruhle, SimpleBioTechPodcast.com [https://simplebiotechpodcast.com/] Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech [http://instagram.com/simplebiotech] If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle [https://angel.co/jamesruhle]

#12 - David Kyle - Treating Malnutrition Worldwide by Repairing the Infant Gut Microbiome

What if I were to tell you that each and every one of us has a universe inside of us that controls our mood, how we age, and even what we're allergic to. A universe inside of our guts filled with trillions of microorganisms that make up our gut microbiome that dictate our lives from the moment we're born. Having a healthy gut microbiome from birth is a massive part of living a long, happy life. However, in recent years, because of changes to how we raise our children researchers have noticed that infants of today have less and less of these extremely important bacteria which can cause life long issues for babies that are born today. This is a serious issue, on a global scale, and it's one that can't be ignored. My guest today is an absolute stud in the world of biotech, and is tackling this issue head on with Evolve Biosystems [https://www.evolvebiosystems.com/]. In this interview I get educated on the different strains of probiotics, why they're so important, why the children born today have less of them and why that is such a problem, as well as some tips for adults that have nuked their guts with things like antibiotics. My guest today... Chief Science Officer and Chairman of Evolve Biosystems, David Kyle. Podcast notes and transcript available here: https://simplebiotechpodcast.com/david-kyle-evolve-biosystems [https://simplebiotechpodcast.com/david-kyle-evolve-biosystems] -James Ruhle, SimpleBioTechPodcast.com [https://simplebiotechpodcast.com/] Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech [http://instagram.com/simplebiotech] If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle [https://angel.co/jamesruhle]

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Imagine if you could turn the characteristics of a cell on and off… or up and down like a volume trigger… constantly tuning things until everything is working just right. It might sound impossible, but that’s exactly what Obsidian therapeutics is working on. I’ll admit, it was tough for me to wrap my mind around this one at first, but my guest today did a fantastic job of explaining things. So without further ado, chief development officer of Obsidian therapeutics, Catherine Stehman-Breen. Podcast notes and transcript available here: https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics [https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics] -James Ruhle, SimpleBioTechPodcast.com [https://simplebiotechpodcast.com/] Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech [http://instagram.com/simplebiotech] If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle [https://angel.co/jamesruhle]

#10 - Shawn Singh - Tackling Anxiety & Depression: A Unique New Approach with a Fraction of the Side Effects

Everyone's dealt with anxiety and depression to some extent, at some point in their lives. It can be debilitating and can cause feelings of hopelessness and helplessness. My guest, Shawn Singh wants to change that. Him and his company, Vistagen Therapeutics are taking on anxiety and depression with their unique bio technology that aims to leave the nasty side effects of anxiety and depression meds behind Vistagen Therapeutics is a publicly traded company on the Nasdaq stock exchange under the ticket VTGN. If you are someone who's dealt with either anxiety or depression this episode is for you. Podcast notes and transcript available here: https://simplebiotechpodcast.com/shawn-singh-vistagen-therapeutics [https://simplebiotechpodcast.com/shawn-singh-vistagen-therapeutics] -James Ruhle, SimpleBioTechPodcast.com [https://simplebiotechpodcast.com/] Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech [http://instagram.com/simplebiotech] If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle [https://angel.co/jamesruhle]